Delighted to speak at #ARDD2023. Our CSO will present preclinical #sarcopenia data on RJx-01, that significantly increases muscle mass, strength, and physical performance in mouse models, and is being evaluated in a Phase 1b #clinicaltrial. rejuvenatebiomed.com ARDD Meeting

Andrea Maier Centre for Healthy Longevity Columbia Psychiatry Charité - Universitätsmedizin Berlin Dr. Evi Mercken, the CSO of Rejuvenate Biomed talks about tackling sarcopenia with a combined treatment of galantamine and metformin #ardd #ardd2023

Launching our #SeriesC #fundraising 🚀 Catch us on stage at #LSXWorldCongressUSA, where we'll unveil our #platformtechnologies and pipeline in age-related diseases. Ready to connect with #investors and #pharma leaders: ow.ly/HTaF50PGj3S LSX Leaders #healthyaging #sarcopenia

📺Tune in to our @TVL feature, where our CEO shared our exciting journey at the #HealthCampus. Get an exclusive glimpse of our #lab at @Bioville and our dedicated colleagues delving into our cutting-edge #Celegans #research. 🔬 ▶ tvl.be/programmas/hea…

🔬👩‍🔬👨‍🔬 Leaning on a strong team in our #lab, moving #aging #research forward! Together, we're on a mission to unlock the secrets of aging and pave the way for a healthier future.💪

🎉 It's our 6th #anniversary, and what an incredible ride it has been! From #insilico discovery to #clinicalstage, developing our #drugdiscovery platforms and a robust #pipeline, thank you all for being a part of our story. Together we are shaping the future of healthy #aging! 🙏

📢 Thrilled to announce positive data from our #Phase1b #clinicaltrial with RJx-01 in #sarcopenia! We confirmed safety, tolerability and #pharmacokinetics with the proprietary formulation. A true milestone in our mission to redefine #aging. #pressrelease: rejuvenatebiomed.com/en/news/positi…

From Rejuvenate Biomed, Dr Silke Hüttner shares her insights from industry and how we can best collaborate on drug development. #ISTRC2023

👋 Join us in welcoming Sandra to our team as Junior Research Associate! Sandra brings a wealth of knowledge and enthusiasm, making her a fantastic addition to our lab family. We’re thrilled to have her on board as we dive deeper into our #agingresearch in #Celegans. 💊🔬

Proud to be part of the Belgian #EconomicMission to Australia. It was a true privilege to showcase our success story in #sarcopenia and #healthyaging and meet HRH Princess Astrid, alongside our distinguished guest Prof. Peter Ebeling, Monash Health AIMSS. #BEmissionAUS

👋 Welcome Gabriel, our new #datascientist! With his expertise, we’re set to take CombinAge, our #insilico #drugdiscovery platform, to new heights, connecting the dots between #drugs and #aging. 💊💡 Find out more about him on our team page: ow.ly/RlHC50Q7N2w #biotech

Proud sponsor of #ICFSR24! #sarcopenia #clinicaltrials

Breakthrough functional outcome from our Phase 1b #clinicaltrial of RJx-01 in #sarcopenia reveal: 💪 Improved muscle strength 🏃 Improved muscle function 🥵 Improved fatigue resistance Full press release: ow.ly/CEob50QG03C #aging #biotech #clinicaltrials #healthyaging

Taking the stage at the Bio CEO & Investor #Conference in New York! We engaged in fruitful discussions, forged new partnerships, and pitched our vision for the future of #healthyaging as pioneers in #clinicalstage #longevity #biotech.

Happy to present our exciting clinical data on muscle strength 🏋️. Looking forward to discuss #scientific and #clinical partnerships and investment opportunities! #together #sarcopenia #aging #LSX LSX Leaders

Rejuvenate Biomed is gearing up to make a splash at #BioEquityEurope Conference in the beautiful San Sebastián. Checkout room 6+7 at 2pm UK Time: Dr Ann Beliën, Founder & CEO, is taking center stage. See you in a minute!

#BIO2024 Rejuvenate Biomed: our novel approach to age-related diseases can make a difference in keeping people healthy as long as possible. 👉 Follow our company presentation today at 3:15pm ET, Theater 4. #BIO2024 #Biotech #InvestorEngagement #businessdevelopment #healthyaging

🚀Excited to announce our partnership with SAS to develop a #DiscoveryTool, to uncover medically relevant insights about drugs, diseases, and biological networks, through explorations of hidden biological patterns, developed on SAS® Viya® rejuvenatebiomed.com/en/news

Rejuvenate Biomed is sponsor and speaker at Aging Research & Drug Discovery (ARDD) 2024, Copenhagen. Committed to advancing groundbreaking research and innovative therapies. 🌱✨ #RejuvenateBiomed #ARDDMeeting #LongevityResearch #HealthyAging #ScientificInnovation #Collaboration

🚀Meet Rejuvenate Biomed next week at LSX World Congress in Boston. Founder & CEO Ann Belien joins the panel discussion: Scaling and Commercialisation on September 11th, from 11:00am – 11:40am ET. 🤝hashtag#LSXWorld hashtag#biotech hashtag#leadership hashtag#healthyaging